🍽️ prednisone,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of prednisone,(prescription) On Probiotics

Rank Probiotic Impact
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces

Bacteria Impacted by prednisone,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Desulfovibrionaceae family Decreases 👪 Source Study
Mucispirillaceae family Decreases 👪 Source Study
Oscillospiraceae family Decreases 👪 Source Study
Rikenellaceae family Decreases 👪 Source Study
Eggerthellaceae family Increases 👪 Source Study
Erysipelotrichaceae family Increases 👪 Source Study
Lachnospiraceae family Increases 👪 Source Study
Sutterellaceae family Increases 👪 Source Study
Bilophila genus Decreases 📓 Source Study High Level Cause Brain Fog(Cognitive impairment)
Mucispirillum genus Decreases 📓 Source Study
Oscillospira genus Decreases 📓 Source Study
Rikenella genus Decreases 📓 Source Study
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Escherichia genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Bacteroides genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Adlercreutzia genus Increases 📓 Source Study
Allobaculum genus Increases 📓 Source Study
Anaerostipes genus Increases 📓 Source Study
Sutterella genus Increases 📓 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
unclassified Bilophila no rank Decreases 👶 Source Study
unclassified Oscillospira no rank Decreases 👶 Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
unclassified Sutterella no rank Increases ⚗️ Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Adlercreutzia no rank Increases 👶 Source Study
unclassified Allobaculum no rank Increases 👶 Source Study
unclassified Anaerostipes no rank Increases 👶 Source Study
unclassified Sutterella no rank Increases 👶 Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O55:H7 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Roseburia intestinalis species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Bilophila wadsworthia species Decreases 👶 Source Study
Mucispirillum schaedleri species Decreases 👶 Source Study
Oscillospira guilliermondii species Decreases 👶 Source Study
Rikenella microfusus species Decreases 👶 Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Bilophila wadsworthia species Decreases 📓 Source Study
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Adlercreutzia caecimuris species Increases 👶 Source Study
Adlercreutzia equolifaciens species Increases 👶 Source Study
Adlercreutzia hattorii species Increases 👶 Source Study
Adlercreutzia mucosicola species Increases 👶 Source Study
Adlercreutzia muris species Increases 👶 Source Study
Allobaculum mucilyticum species Increases 👶 Source Study
Allobaculum stercoricanis species Increases 👶 Source Study
Anaerostipes butyraticus species Increases 👶 Source Study
Anaerostipes caccae species Increases 👶 Source Study
Anaerostipes hadrus species Increases 👶 Source Study
Anaerostipes rhamnosivorans species Increases 👶 Source Study
Anaerostipes sp. 3_2_56FAA species Increases 👶 Source Study
Anaerostipes sp. 5_1_63FAA species Increases 👶 Source Study
Sutterella faecalis species Increases 👶 Source Study
Sutterella massiliensis species Increases 👶 Source Study
Sutterella megalosphaeroides species Increases 👶 Source Study
Sutterella parvirubra species Increases 👶 Source Study
Sutterella sanguinus species Increases 👶 Source Study
Sutterella seckii species Increases 👶 Source Study
Sutterella stercoricanis species Increases 👶 Source Study
Sutterella wadsworthensis species Increases 👶 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of prednisone,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.3 0.3
Acne 0.9 0.9
ADHD 1.3 0.2 5.5
Age-Related Macular Degeneration and Glaucoma 0.5 0.4 0.25
Allergic Rhinitis (Hay Fever) 0.6 0.6
Allergies 0.8 1.4 -0.75
Allergy to milk products 0.7 0.6 0.17
Alopecia (Hair Loss) 0.2 1.5 -6.5
Alzheimer's disease 3.2 0.9 2.56
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.5 1.3 -1.6
Ankylosing spondylitis 1.6 0.6 1.67
Anorexia Nervosa 1 0.2 4
Antiphospholipid syndrome (APS) 0.9 0.3 2
Asthma 0.2 0.5 -1.5
Atherosclerosis 0.2 1.1 -4.5
Atrial fibrillation 0.3 0.6 -1
Autism 4 2.9 0.38
Barrett esophagus cancer 0.5 0.1 4
benign prostatic hyperplasia 0.2 0.3 -0.5
Bipolar Disorder 0.6 0.2 2
Brain Trauma 0.2 -0.2
Carcinoma 1.4 0.8 0.75
Celiac Disease 1.7 1.3 0.31
Cerebral Palsy 0.7 0.2 2.5
Chronic Fatigue Syndrome 1.3 1.1 0.18
Chronic Kidney Disease 0.7 0.2 2.5
Chronic Lyme 0.2 -0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.6 0.7 -0.17
Chronic Urticaria (Hives) 0.8 0.6 0.33
Coagulation / Micro clot triggering bacteria 1.5 0.3 4
Colorectal Cancer 2.8 1.2 1.33
Constipation 0.8 0.5 0.6
Coronary artery disease 0.3 0.9 -2
COVID-19 3.1 3.1 0
Crohn's Disease 3.6 2.4 0.5
cystic fibrosis 0.7 0.5 0.4
deep vein thrombosis 1.3 0.3 3.33
Depression 3.6 2.6 0.38
Dermatomyositis 0.1 0.1
Eczema 0.2 1 -4
Endometriosis 1.4 1.4
Eosinophilic Esophagitis 0.2 0.2
Epilepsy 1.2 1.8 -0.5
erectile dysfunction 0.6 -0.6
Fibromyalgia 0.8 0.2 3
Functional constipation / chronic idiopathic constipation 2.2 0.9 1.44
gallstone disease (gsd) 0.8 1 -0.25
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.7 0.1 6
Generalized anxiety disorder 0.9 0.7 0.29
Glioblastoma 0.9 0.4 1.25
Gout 0.3 0.3 0
Graves' disease 1.1 0.7 0.57
Halitosis 0.3 0.1 2
Hashimoto's thyroiditis 0.2 0.6 -2
Hidradenitis Suppurativa 0.6 0.6
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.8 0.8
hypercholesterolemia (High Cholesterol) 0.3 0.6 -1
hyperglycemia 0.8 0.5 0.6
Hyperlipidemia (High Blood Fats) 0.3 0.3
hypersomnia 0.3 -0.3
hypertension (High Blood Pressure 1.4 3 -1.14
Hypothyroidism 1.1 0.3 2.67
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 1.3 -1.3
Inflammatory Bowel Disease 1.9 2 -0.05
Insomnia 0.2 0.5 -1.5
Intelligence 1.5 0.3 4
Intracranial aneurysms 0.4 0.4
Irritable Bowel Syndrome 2.5 2.3 0.09
Liver Cirrhosis 1.2 1.5 -0.25
Long COVID 3.4 3.4 0
Low bone mineral density 0.3 0.4 -0.33
Lung Cancer 0.5 0.3 0.67
ME/CFS with IBS 0.1 0.3 -2
ME/CFS without IBS 0.1 0.3 -2
Metabolic Syndrome 3.9 4.6 -0.18
Mood Disorders 5.1 2.6 0.96
multiple chemical sensitivity [MCS] 0.7 0.7
Multiple Sclerosis 4 0.7 4.71
Neuropathy (all types) 0.1 0.5 -4
neuropsychiatric disorders (PANDAS, PANS) 1.3 1.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.6 1.1 -0.83
Obesity 2.3 2.9 -0.26
obsessive-compulsive disorder 2.8 1.2 1.33
Osteoarthritis 0.4 0.3 0.33
Osteoporosis 1.2 0.3 3
pancreatic cancer 0.4 0.4
Parkinson's Disease 2.6 2.1 0.24
Polycystic ovary syndrome 0.6 1.6 -1.67
Premenstrual dysphoric disorder 0.1 -0.1
primary biliary cholangitis 0.7 -0.7
Psoriasis 0.6 0.6 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.5 1.7 1.06
Rosacea 0.2 -0.2
Schizophrenia 2.4 0.7 2.43
scoliosis 0.3 0.6 -1
sensorineural hearing loss 0.6 0.6
Sjögren syndrome 0.7 0.3 1.33
Sleep Apnea 1.1 0.7 0.57
Small Intestinal Bacterial Overgrowth (SIBO) 1 1
Stress / posttraumatic stress disorder 1.9 1.6 0.19
Systemic Lupus Erythematosus 1.3 0.4 2.25
Tic Disorder 0.5 0.5
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 0.8 1.5 -0.88
Type 2 Diabetes 3 3.4 -0.13
Ulcerative colitis 2.1 1.6 0.31
Unhealthy Ageing 1.4 0.7 1

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)